UTHR FY 2022 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.9B+14.9% YoY

Gross Profit

$1.8B92.4% margin

Operating Income

$980M50.6% margin

Net Income

$727M37.6% margin

EPS (Diluted)

$15.00

Cash Flow

Operating Cash Flow

$803M

Free Cash Flow

$664M

Stock-Based Comp.

$107M

Balance Sheet

Total Assets

$6.0B

Total Liabilities

$1.2B

Stockholders' Equity

$4.8B

Cash & Equivalents

$961M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.9B	$1.7B	+14.9%
Gross Profit	$1.8B	$1.6B	+14.5%
Operating Income	$980M	$556M	+76.2%
Net Income	$727M	$476M	+52.9%